1Thomsen HS, Moreos SK. Contrast media and the kidney. European Sociely of Urogenit Radiology(ESUR) guidelines[J]. Br J Radiol, 2003,76 : 513-518.
2Agrawal M, Stouffer GA. Contrast induced nephropathy after angiography[J]. Am Mt Sci, 2002,223:252.
3Marenzi G, Bartorelli AL. Hemofiltration in the prevention of radiocontrast agent mduced nephropathy [J]. Minerva Anestesiol, 2004,70:189-191.
4Fishbane S, Durham JH, Matzo K,et al. Nacetylcysteine in the prevention of radiocontra induced nephropathy[J]. J Am Soc Nephtol, 2004, 15 (2): 251- 260.
5Richard A, Zager AC, Johnson, et al. Radiographic contrast media induced tubular injury: evaluation of ox/dantstress and plasma membrane integrity [J]. Kidneynt , 2003,64: 128.
6Hizoh I, Hailer C. Radiocontrast induced renal tubular cell apoptosis[J]. Invest Radial, 2002, 37 (8): 428- 534.
7Asif A, Preston RA, Roth D. Radiocontrast induced nephropathy[J]. Am J Ther ,2003,10(2): 137-147.
6Nikolsky E, Aymong ED. Radiocontrast nephropathy: identifying the high-risk patient and the implications of exacerbating renal function. Rev Cardiovasc Med, 2003,4Suppl 1:87-814.
7Hetzel GR, May P, Hollenbeck M, et al.Assessment of radiocontrast media induced renalby color coded duplexsonography. Ren Fail, 2001,23( 1 ) : 77-83
8Dzgoeva FU, Kutyrina IM. T hromboxane A2 and prostacyclin in patients with chronic glomerulonephritis and coronary heart disease in contrast media nephrotoxicity. Protective effects of calcium antagonists. Ter Arkh, 2000, 42(6):42-45.
9Heyman S N. Radiocontrast Agents Induce Endothelin Release in Vivo and in Vitro.Jam Soc Nephrol, 1992,3 ( 1 ) :58-65.
10Idmyd SD, Bosentan A. An Oral Active Indothelin Antagonist: Effect on the Renal Response to Contrast Media. Radiology, 1995,196 : 661-665.
2Mehran R,Nikolsky E.Contrast-induced nephropathy:definition,epidemiology,and patients at risk[J].Kidney Int Suppl,2006,(100):S11-15.
3Toprak O,Cirit M.Risk factors and therapy strategies for contrastinduced nephropathy[J].Ren Fail,2006,28 (5):365-381.
4McCullough PA,Adam A,Becker CR,et al.Epidemiology and prognostic implications of contrast-induced nephropathy[J].Am J Cardiol,2006,98(6A):5K-13K.
5Pannu N,Wiebe N,Tonelli M,et al.Prophylaxis strategies for contrast-induced nephropathy[J].JAMA,2006,295 (23):2765-2779.
6Agrawal M,Stouffer GA.Cardiology Grand Rounds from The University of North Carolina at Chapel Hill.Contrast induced nephropathy after angiography[J].AmJ Med Sci,2002,323(5):252-258.
7Tauber S,Menger MD,Lehr HA.Microvascular in vivo assessment of reperfusion injury:significance of prostaglandin E(1) and I(2) in postischemic “no-reflow” and “reflow-paradox”[J].J Surg Res,2004,120(1):1-11.
8Mehran R. Contrast -induced nephropathy remains a seri- ous complication of PCI [ J ]. J Interv Cardiol,2007,20 (3) : 236 - 240.
9Idee J, Boehm J, Prigent P, et al. Role of Apoptosis in the pathogenesis of Contrast Media - induced Nephropathy and Hints for its Passible Prevention by Drug Treatment [ J ]. Anti- inflammatory & Anui -Allergy Agents in Medicinal Chemistry, 2006,5 : 139 - 146.
10Mehran R, Aymong ED, Nikoisky E, et al. A simple risk score for prediction of contrast - induced nephropathy after percu- taneous coronary intervention:development and initial valida- tion[J]. J Am Coil Cardiol,2004,44(7) :1393 -1399.
